A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata
- 1 December 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 101 (Pt B) , 108186
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areataDermatology Reports, 2017
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areataJournal of the American Academy of Dermatology, 2017
- Alopecia areataNature Reviews Disease Primers, 2017
- Trichoscopic clues for diagnosis of alopecia areata and trichotillomania in AsiansInternational Journal of Dermatology, 2017
- Treatment of Alopecia Areata With Topical SensitizersDermatitis®, 2015
- Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata – a large retrospective study on 142 patients with a self‐controlled designJournal of the European Academy of Dermatology and Venereology, 2011
- Alopecia areata updateJournal of the American Academy of Dermatology, 2010
- Alopecia areata: topical immunotherapy treatment with diphencyproneJournal of the European Academy of Dermatology and Venereology, 2007
- Topical immunotherapy with diphencyprone in the treatment of extensive and/or long‐lasting alopecia areataJournal of the European Academy of Dermatology and Venereology, 2005
- Alopecia areata investigational assessment guidelines–Part IIJournal of the American Academy of Dermatology, 2004